English
Français
Deutsch
Italiano
Português
Русский
Español
ไทย
Türkçe
简体中文
日本語
한국어
हिन्दी
On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its holdings, with a significant sale of DraftKings Inc (NASDAQ:DKNG) shares and the addition of Moderna Inc (NASDAQ:MRNA) stock. This move comes amidst DraftKings’ positive earnings report and Moderna’s challenges with vaccine demand.
The DraftKings Trade: Despite a strong earnings report where DraftKings climbed on third-quarter revenue and EPS beat, Ark Invest divested a significant portion of its stake in the company.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
